Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

US (CA): A cannabis IP-licensing company has officially launched

Cannabis industry pioneers, Dale Hunt, PhD, JD, Ethan Russo, MD, and Robert C. Clarke have joined forces to create Breeder’s Best, the first cannabis company to focus on intellectual property (IP) protection for independent plant breeders and licensing IP for access to markets worldwide. "Breeder’s Best brings a global plant-licensing model, proven successful in other agriculture industries, to cannabis," the team with the company explains.

"The liberalization of global cannabis laws and growing public acceptance of cannabis have created a rapidly escalating demand for cannabis flower, as well as therapeutics and products made with cannabis. According to a report by Prohibition Partners, the international cannabis industry is projected to grow to more than $103.6 billion by 2024."

While the cannabis industry presents significant opportunity, there exists a critical disconnect that separates the creativity of breeders from the markets that are demanding products with unique and proven genetic profiles. Additionally, there is typically very little IP protection to support good partnerships between breeders and cannabis brands. Breeder’s Best will connect these two key stakeholders while legally protecting the genetic inventiveness of breeders.   

Breeder’s Best founder and CEO Dale Hunt says, “Our mission is to connect the best Cannabis genetics to the greatest needs and most promising commercial opportunities. To do that, we have assembled an unparalleled team of experts with deep experience at every level of the cannabis supply chain. As the industry matures, Breeder’s Best will be positioned to meet the demands of the increasingly professional and GMP-oriented marketplace while doing business in a way that benefits breeders and directs profitable and reliable business to growers who may otherwise be left behind. With our vision, team, model, know-how, and relationships, Breeder’s Best is poised to become the global leader in patented cannabis genetics and related products.” Dr. Hunt has been practicing IP law for 23 years. He has a PhD in plant cellular and molecular biology and has obtained thousands of patents and plant variety rights for his clients in more than 30 countries.

“Cannabis use is finally normalizing. At Breeder’s Best, we present independent Cannabis breeders the opportunity to protect their unique varieties and assist them in placing those genetics in lucrative markets. This is a great service to breeders who would prefer to focus on the art and science of breeding, instead of dealing with the mechanics of commercialization,” said Breeder’s Best Director of Agronomy and Genetics, Robert C. Clarke. Mr. Clarke is a 40-year cannabis industry veteran, revered for his books Marijuana Botany, published in 1982, and Cannabis: Evolution and Ethnobotany, published in 2013. 

The Cannabis plant produces over 450 chemical components, many of which are potentially therapeutic. However, decades of cannabis prohibition have resulted in a lack of genetic diversity worldwide and a predominance of only a small fraction of potential agents.

“We have just begun to scratch the surface of everything that cannabis can do to improve and enhance our lives,” said Dr. Ethan Russo. “That’s what Breeder’s Best will do. Identifying, selectively breeding for and utilizing specific chemical components will truly transform medicine in the coming decades.” Dr. Russo is a board-certified neurologist, preeminent medical cannabis expert, author of more than 50 peer-reviewed medical journal articles and a veteran of GW Pharmaceuticals where he served as Senior Medical Advisor as well as the Sativex® and Epidiolex® clinical trial Study Physician and Medical Monitor.

For more information:
Breeder's Best
11440 W. Bernardo Court, Suite 300, San Diego, CA 92127
070-882-7333
info@breedersbest.com 
breedersbest.com  

Publication date: